Lupin has got EIR report from USFDA on inspection closure
Lupin, the pharma major has got an establishment inspection report (EIR) from the USFDA on closure of inspection of its Mandideep and Aurangabad facilities. Lupin...
Tag : Lupin
Lupin Outlook for the Week (May 23, 2016 – May 27, 2016)
EquityPandit’s Outlook for Lupin for the week (May 23, 2016 – May 27, 2016): LUPIN: Lupin closed the week on negative note losing around...
Lupin has reported Q4 PAT at Rs 807 crore, up 47.5%
Lupin has reported a profit after tax growth of 47.53 percent to Rs 807 crore for the quarter ending March 31, 2016. The company, during...
Lupin Outlook for the Week (May 16, 2016 – May 20, 2016)
EquityPandit’s Outlook for Lupin for the week (May 16, 2016 – May 20, 2016): LUPIN: Lupin closed the week on absolutely flat note. As...
Lupin Outlook for the Week (May 09, 2016 – May 13, 2016)
EquityPandit’s Outlook for Lupin for the week (May 09, 2016 – May 13, 2016): LUPIN: Lupin closed the week on negative note losing around...
Lupin Outlook for the Week (May 02, 2016 – May 06, 2016)
EquityPandit’s Outlook for Lupin for the week (May 02, 2016 – May 06, 2016): LUPIN: Lupin closed the week on positive note gaining around...
Lupin Outlook for the Week (April 25, 2016 – April 29, 2016)
EquityPandit’s Outlook for Lupin for the week (April 25, 2016 – April 29, 2016): LUPIN: Lupin closed the week on positive note gaining...
Lupin Outlook for the Week (April 18, 2016 – April 22, 2016)
EquityPandit’s Outlook for Lupin for the week (April 18, 2016 – April 22, 2016): LUPIN: Lupin closed the week on positive note gaining...
Lupin Outlook for the Week (April 11, 2016 – April 13, 2016)
EquityPandit’s Outlook for Lupin for the week (April 11, 2016 – April 13, 2016): LUPIN: Lupin closed the week on positive note gaining...
Lupin has launched generic insomnia drug in US
A generic insomnia drug, Zolpidem Sublingual tablets has been launche by the drug major Lupin in the US market with 180 days of marketing exclusivity....